Lipopolysaccharide-antagonizing effects of diphosphoryl lipid A from Rhodobacter sphaeroides (Rs-DPLA). 1994

J Hofman, and N Qureshi, and K Takayama, and N Kalin, and C L Manthey, and S N Vogel, and M G Lei, and D C Morrison
Czech Academy of Sciences, Prague.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008050 Lipid A Lipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties.
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002240 Carbohydrate Sequence The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS. Carbohydrate Sequences,Sequence, Carbohydrate,Sequences, Carbohydrate
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012242 Rhodobacter sphaeroides Spherical phototrophic bacteria found in mud and stagnant water exposed to light. Rhodopseudomonas sphaeroides,Rhodobacter spheroides,Rhodopseudomonas spheroides
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

J Hofman, and N Qureshi, and K Takayama, and N Kalin, and C L Manthey, and S N Vogel, and M G Lei, and D C Morrison
July 2001, Journal of immunology (Baltimore, Md. : 1950),
J Hofman, and N Qureshi, and K Takayama, and N Kalin, and C L Manthey, and S N Vogel, and M G Lei, and D C Morrison
January 1998, The American journal of physiology,
J Hofman, and N Qureshi, and K Takayama, and N Kalin, and C L Manthey, and S N Vogel, and M G Lei, and D C Morrison
August 1997, Infection and immunity,
J Hofman, and N Qureshi, and K Takayama, and N Kalin, and C L Manthey, and S N Vogel, and M G Lei, and D C Morrison
April 1989, Infection and immunity,
J Hofman, and N Qureshi, and K Takayama, and N Kalin, and C L Manthey, and S N Vogel, and M G Lei, and D C Morrison
May 1997, Infection and immunity,
J Hofman, and N Qureshi, and K Takayama, and N Kalin, and C L Manthey, and S N Vogel, and M G Lei, and D C Morrison
September 1994, FEMS immunology and medical microbiology,
J Hofman, and N Qureshi, and K Takayama, and N Kalin, and C L Manthey, and S N Vogel, and M G Lei, and D C Morrison
January 1991, Infection and immunity,
J Hofman, and N Qureshi, and K Takayama, and N Kalin, and C L Manthey, and S N Vogel, and M G Lei, and D C Morrison
July 1992, Infection and immunity,
J Hofman, and N Qureshi, and K Takayama, and N Kalin, and C L Manthey, and S N Vogel, and M G Lei, and D C Morrison
January 1991, Infection and immunity,
J Hofman, and N Qureshi, and K Takayama, and N Kalin, and C L Manthey, and S N Vogel, and M G Lei, and D C Morrison
March 1995, Infection and immunity,
Copied contents to your clipboard!